Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Pharm Res. 2010 Apr 13;27(11):2356–2364. doi: 10.1007/s11095-010-0119-5

Figure 4.

Figure 4

(A) In vitro inhibition of S. mutans biofilm formation on HA discs. (B) In vitro treatment of preformed S. mutans biofilm on HA discs. TBMP123, tooth-binding P123 micelle containing 20% of ALN-F127; NBMP123, non-binding P123 micelle containing 20% of F127 instead of ALN-F127; EBMP123, empty (does not contain triclosan) tooth-binding micelle P123 containing 20% of ALN-F127; UTB, untreated blank control. Data are expressed as mean CFU/biofilm ±SD, n=3. The asterisks indicate statistically significant differences (p<0.05) between groups (indicated by connecting lines above the bars on the graphs).